EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Editorial Archive

Defining Success in Rare Disease Paediatric Trials

Rare diseases are often chronic conditions that begin to manifest during childhood.1 The effects of disease change everything from direct consequences of having the ...
Continue Reading →
Regional News

Lilly and Boehringer’s Jardiance, trailing AZ’s Farxiga in chronic kidney disease, posts efficacy win

After a series of wins in heart failure, Eli Lilly and Boehringer Ingelheim are pumping the breaks on a late-stage Jardiance trial in chronic kidney disease (CKD) tha...
Continue Reading →
Regional News

After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug Aspaveli

After rare disease drugmaker Sobi reportedly had a buyout scuppered by pharma giant AstraZeneca, the company has picked up a win that stands to bolster its Aspaveli l...
Continue Reading →
Europe

Worldwide Clinical Trials partners with Datavant for real-world data pilot study

Worldwide Clinical Trials and Datavant have partnered to explore the reasons clinical trials in neurodegenerative diseases fail, and how big data tactics can improve...
Continue Reading →
Europe

Too few women take part in many CVD clinical trials

Women make up a lower than expected proportion of participants in many clinical trials for cardiovascular disease, US researchers have found. The authors of the stud...
Continue Reading →
Catalyst: 12th January 2026
Quotient